Published Ahead of Print | Journal of Nuclear Medicine (2024)

Main menu

User menu

Search

  • Advanced search

Advanced Search

October 24, 2024

  • Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy

    Adriana Amerein, Christoph Maurer, Malte Kircher, Alexander Gäble, Anne Krebold, Andreas Rinscheid, Oliver Viering, Christian H. Pfob, Ralph A. Bundschuh, Lars Behrens, Arthur JAT Braat, Ansgar Berlis and Constantin Lapa

    Journal of Nuclear Medicine October 24, 2024, jnumed.124.268217; DOI: https://doi.org/10.2967/jnumed.124.268217

  • Head-to-Head Comparison of [68Ga]Ga-NOTA-RM26 and [18F]FDG PET/CT in Patients with Gastrointestinal Stromal Tumors: A Prospective Study

    Rongxi Wang, Weiming Kang, Zhen Liu, Yumin Zheng, Huimin Sui, Linlin Li, Jiarou Wang, Jialin Xiang, Xingtong Peng, Xiaoyuan Chen, Zhaohui Zhu and Jingjing Zhang

    Journal of Nuclear Medicine October 24, 2024, jnumed.124.267810; DOI: https://doi.org/10.2967/jnumed.124.267810

  • Modeling PET Data Acquired During Nonsteady Conditions: What If Brain Conditions Change During the Scan?

    Evan D. Morris, Gaelle M. Emvalomenos, Jocelyn Hoye and Steven R. Meikle

    Journal of Nuclear Medicine October 24, 2024, jnumed.124.267494; DOI: https://doi.org/10.2967/jnumed.124.267494

  • MIRD Pamphlet No. 31: MIRDcell V4—Artificial Intelligence Tools to Formulate Optimized Radiopharmaceutical Cocktails for Therapy

    Sumudu Katugampola, Jianchao Wang and Roger W. Howell

    Journal of Nuclear Medicine October 24, 2024, jnumed.123.267238; DOI: https://doi.org/10.2967/jnumed.123.267238

  • [18F]F-AraG Uptake in Vertebral Bone Marrow May Predict Survival in Patients with Non–Small Cell Lung Cancer Treated with Anti-PD-(L)1 Immunotherapy

    Jelena Levi, Millie Das, Minal S. Vasanawala, Deepti Behl, Martin Pomper, Patrick M. Forde, Erica Nakajima, James Sayre, Bin Shen, Hilda Cabrera, Niko Del Mar, Michele Gullen, Michele Pierini, Laura Cox, Ojaswita Lokre, Timothy Perk and Hee-Don Chae

    Journal of Nuclear Medicine October 24, 2024, jnumed.124.268253; DOI: https://doi.org/10.2967/jnumed.124.268253

October 17, 2024

  • Open Access

    Improved Localization of Insulinomas Using 68Ga-NODAGA-Exendin-4 PET/CT

    Marti Boss, Olof Eriksson, Kirsi Mikkola, Annemarie Eek, Maarten Brom, Mijke Buitinga, Adrienne H. Brouwers, Irina Velikyan, Beatrice Waser, Saila Kauhanen, Olof Solin, Camille Marciniak, Barbro Eriksson, Jean-Claude Reubi, Cyrielle Aveline, Damian Wild, Francois Pattou, Jean-Noel Talbot, Johannes Hofland, Anders Sundin, Pirjo Nuutila, John Hermans and Martin Gotthardt

    Journal of Nuclear Medicine October 17, 2024, jnumed.124.268158; DOI: https://doi.org/10.2967/jnumed.124.268158

  • One Bite from the Apple, One Bite from the Orange in the PRECISE-MDT Study

    Andrei Fodor, Cristiano Pini, Gaia Ninatti, Nadia Di Muzio and Arturo Chiti

    Journal of Nuclear Medicine October 17, 2024, jnumed.124.268395; DOI: https://doi.org/10.2967/jnumed.124.268395

  • Limitations of Retrospective Study Design and Potential Bias in the PRECISE-MDT Study

    Tadashi Watabe

    Journal of Nuclear Medicine October 17, 2024, jnumed.124.268447; DOI: https://doi.org/10.2967/jnumed.124.268447

  • Reply: One Bite from the Apple, One Bite from the Orange in the PRECISE-MDT Study and Limitations of Retrospective Study Design and Potential Bias in the PRECISE-MDT Study

    Matteo Bauckneht, Francesco Lanfranchi and Liliana Belgioia

    Journal of Nuclear Medicine October 17, 2024, jnumed.124.268781; DOI: https://doi.org/10.2967/jnumed.124.268781

  • Open Access

    SNMMI Procedure Standard/EANM Practice Guideline for Brain [18F]FDG PET Imaging, Version 2.0

    Javier Arbizu, Silvia Morbelli, Satoshi Minoshima, Henryk Barthel, Philip Kuo, Donatienne Van Weehaeghe, Neil Horner, Patrick M. Colletti and Eric Guedj

    Journal of Nuclear Medicine October 17, 2024, jnumed.124.268754; DOI: https://doi.org/10.2967/jnumed.124.268754

October 10, 2024

  • Open Access

    uPAR Immuno-PET in Pancreatic Cancer, Aging, and Chemotherapy-Induced Senescence

    Edwin C. Pratt, Riccardo Mezzadra, Amanda Kulick, Spencer Kaminsky, Zachary V. Samuels, Angelique Loor, Elisa de Stanchina, Scott W. Lowe and Jason S. Lewis

    Journal of Nuclear Medicine October 10, 2024, jnumed.124.268278; DOI: https://doi.org/10.2967/jnumed.124.268278

  • Theranostics for Meningioma on the Rise: New EANM/EANO/RANO/SNMMI Guidelines Pave the Way to Improved Patient Outcomes Using Radiolabeled Somatostatin Receptor Ligands

    Nathalie L. Albert, Matthias Preusser, Norbert Galldiks and Jana Ivanidze

    Journal of Nuclear Medicine October 10, 2024, jnumed.124.268314; DOI: https://doi.org/10.2967/jnumed.124.268314

  • Granzyme B PET/CT Imaging Evaluates Early Response to Immunotherapy in Gastric Cancer

    Qiufang Liu, Xiaoping Xu, Ziyi Yang, Jianping Zhang, Jindian Li, Ying Qiao, Silong Hu, Xiaosheng Liu, Weijian Guo and Shaoli Song

    Journal of Nuclear Medicine October 10, 2024, jnumed.124.267529; DOI: https://doi.org/10.2967/jnumed.124.267529

  • Diagnostic Radiopharmaceuticals: A Sustainable Path to the Improvement of Patient Care

    Andrei Gafita, Andrew R. Menard and Lilja B. Solnes

    Journal of Nuclear Medicine October 10, 2024, jnumed.124.268608; DOI: https://doi.org/10.2967/jnumed.124.268608

  • Impact of 18F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial

    Kai Jannusch, Lale Umutlu, Julian Kirchner, Nils-Martin Bruckmann, Janna Morawitz, Ken Herrmann, Wolfgang Peter Fendler, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Eugen Ruckhäberle, Martin Stuschke, Werner Schmid, Frederik Giesel, Lena Häberle, Irene Esposito, Wilfried Budach, Johannes Grueneisen, Christiane Matuschek, Bernd Kowall, Andreas Stang, Gerald Antoch and Christian Buchbender

    Journal of Nuclear Medicine October 10, 2024, jnumed.124.268065; DOI: https://doi.org/10.2967/jnumed.124.268065

October 3, 2024

  • Cardiac Neuroendocrine Tumor Metastases on 68Ga-DOTATATE PET/CT: Identification and Prognostic Significance

    Hwan Lee, Ahmad S. Alhamshari, Vandan Patel, Abhijit Bhattaru, Chaitanya Rojulpote, Mahesh K. Vidula, Daniel A. Pryma and Paco E. Bravo

    Journal of Nuclear Medicine October 3, 2024, jnumed.124.267948; DOI: https://doi.org/10.2967/jnumed.124.267948

  • Open Access

    Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy

    Jeremie Calais, Michael J. Morris, Ayse Tuba Kendi, Arash Rezazadeh Kalebasty, Ronald Tutrone, Michael J. Anderson and Oliver Sartor

    Journal of Nuclear Medicine October 3, 2024, jnumed.124.268363; DOI: https://doi.org/10.2967/jnumed.124.268363

  • Impact of 18F-FES PET/CT on Clinical Decisions in the Management of Recurrent or Metastatic Breast Cancer

    Jeongryul Ryu, Jaewon Hyung, Sangwon Han, Jae Ho Jeong, Sae Byul Lee, Tae-Kyung Robyn Yoo, Jisun Kim, Hee Jeong Kim, Il Yong Chung, Beom Seok Ko, Jong Won Lee, Byung Ho Son, Hyehyun Jeong, Jin-Hee Ahn, Kyung Hae Jung, Sung-Bae Kim and Dae Hyuk Moon

    Journal of Nuclear Medicine October 3, 2024, jnumed.124.267913; DOI: https://doi.org/10.2967/jnumed.124.267913

  • The Updated Registry of Fast Myocardial Perfusion Imaging with Next-Generation SPECT (REFINE SPECT 2.0)

    Robert J.H. Miller, Mark Lemley, Aakash Shanbhag, Giselle Ramirez, Joanna X. Liang, Valerie Builoff, Paul Kavanagh, Tali Sharir, M. Timothy Hauser, Terrence D. Ruddy, Mathews B. Fish, Timothy M. Bateman, Wanda Acampa, Andrew J. Einstein, Sharmila Dorbala, Marcelo F. Di Carli, Attila Feher, Edward J. Miller, Albert J. Sinusas, Julian Halcox, Monica Martins, Philipp A. Kaufmann, Damini Dey, Daniel S. Berman and Piotr J. Slomka

    Journal of Nuclear Medicine October 3, 2024, jnumed.124.268292; DOI: https://doi.org/10.2967/jnumed.124.268292

  • Preclinical Evaluation of 226Ac as a Theranostic Agent: Imaging, Dosimetry, and Therapy

    Helena Koniar, Luke Wharton, Aidan Ingham, Ana Paulina Morales Oliver, Helen Merkens, Cristina Rodríguez-Rodríguez, Peter Kunz, Valery Radchenko, Hua Yang, Arman Rahmim, Carlos Uribe and Paul Schaffer

    Journal of Nuclear Medicine October 3, 2024, jnumed.124.267999; DOI: https://doi.org/10.2967/jnumed.124.267999

  • Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease

    Masatoshi Hotta, Grace Hyun J. Kim, Vilasinee Rerkpichaisuth, Pang Yu Teng, Wesley R. Armstrong, Giuseppe Carlucci, Magnus Dahlbom, Fereidoun Abtin, Shahrzad M. Lari, Gregory A. Fishbein, Johannes Czernin, Elizabeth R. Volkmann, S. Sam Weigt and Jeremie Calais

    Journal of Nuclear Medicine October 3, 2024, jnumed.124.268351; DOI: https://doi.org/10.2967/jnumed.124.268351

  • Routine Use of [64Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive Scans

    Esben Andreas Carlsen, Mathias Loft, Camilla Bardram Johnbeck, Ulrich Knigge, Seppo W. Langer, Jann Mortensen, Lotte Enevoldsen, Peter Oturai and Andreas Kjaer

    Journal of Nuclear Medicine October 3, 2024, jnumed.124.267939; DOI: https://doi.org/10.2967/jnumed.124.267939

  • U.S. Imaging Costs

    Michal Horný, Ken Herrmann and Johannes Czernin

    Journal of Nuclear Medicine October 3, 2024, jnumed.124.268825; DOI: https://doi.org/10.2967/jnumed.124.268825

  • Open Access

    The Role of Molecular Imaging in Precision Oncology

    James R. Bading and Joanne E. Mortimer

    Journal of Nuclear Medicine October 3, 2024, jnumed.124.268036; DOI: https://doi.org/10.2967/jnumed.124.268036

  • Arrhythmias in Nongranulomatous Myocarditis: Is There a Role for PET?

    Matthieu Pelletier-Galarneau, François Simard, Rafik Tadros and Maxime Tremblay-Gravel

    Journal of Nuclear Medicine October 3, 2024, jnumed.124.268033; DOI: https://doi.org/10.2967/jnumed.124.268033

  • Association of Free-to-Total PSA Ratio and 18F-DCFPyL Prostate-Specific Membrane Antigen PET/CT Findings in Patients with Biochemical Recurrence After Radical Prostatectomy: A Prospective Single-Center Study

    Rui M. Bernardino, Katherine Lajkosz, Leyi B. Yin, Rashid K. Sayyid, Marian Wettstein, Harkanwal Randhawa, Jessica G. Cockburn, Sayeed Ahmed, Rosita Thomassian, Eleftherios Diamandis, Ur Metser, Alejandro Berlin and Neil E. Fleshner

    Journal of Nuclear Medicine October 3, 2024, jnumed.124.267877; DOI: https://doi.org/10.2967/jnumed.124.267877

  • Validation of an Artificial Intelligence–Based Prediction Model Using 5 External PET/CT Datasets of Diffuse Large B-Cell Lymphoma

    Maria C. Ferrández, Sandeep S.V. Golla, Jakoba J. Eertink, Sanne E. Wiegers, Gerben J.C. Zwezerijnen, Martijn W. Heymans, Pieternella J. Lugtenburg, Lars Kurch, Andreas Hüttmann, Christine Hanoun, Ulrich Dührsen, Sally F. Barrington, N. George Mikhaeel, Luca Ceriani, Emanuele Zucca, Sándor Czibor, Tamás Györke, Martine E.D. Chamuleau, Josée M. Zijlstra and Ronald Boellaard; on behalf of the PETRA Consortium

    Journal of Nuclear Medicine October 3, 2024, jnumed.124.268191; DOI: https://doi.org/10.2967/jnumed.124.268191

  • Freehand SPECT Combined with 3-Dimensional Light Detection and Ranging as Alternative Means of Specimen Scanning During Prostate Cancer Surgery

    Giusi Pisano, Matthias N. van Oosterom, Anne-Claire Berrens, Leon J. Slof, Daphne D.D. Rietbergen, Henk G. van der Poel, Pim J. van Leeuwen and Fijs W.B. van Leeuwen

    Journal of Nuclear Medicine October 3, 2024, jnumed.124.268256; DOI: https://doi.org/10.2967/jnumed.124.268256

September 26, 2024

  • [18F]AlF-NOTA-FAPI-04 PET/CT for Predicting Pathologic Response of Resectable Esophageal Squamous Cell Carcinoma to Neoadjuvant Camrelizumab and Chemotherapy: A Phase II Clinical Trial

    Yinjun Dong, Zhendan Wang, Xinying Hu, Yuhong Sun, Jingjie Qin, Qiming Qin, Shuguang Liu, Shuanghu Yuan, Jinming Yu and Yuchun Wei

    Journal of Nuclear Medicine September 26, 2024, jnumed.124.268557; DOI: https://doi.org/10.2967/jnumed.124.268557

  • Summary: Appropriate Use Criteria for the Use of Nuclear Medicine in Fever of Unknown Origin

    Christopher J. Palestro, Gad Abikhzer, Zvi Bar-Sever, Twyla Bartel, Rebecca Brady, Erin E. Grady, Ora Israel, Sanjay K. Jain, Sheetal Kandiah, Machaba M. Sathekge and Barry L. Shulkin

    Journal of Nuclear Medicine September 26, 2024, jnumed.124.268797; DOI: https://doi.org/10.2967/jnumed.124.268797

  • Open Access

    Preclinical Investigation of [212Pb]Pb-DOTAM-GRPR1 for Peptide Receptor Radionuclide Therapy in a Prostate Tumor Model

    Amal Saidi, Tania A. Stallons, Amy G. Wong and Julien J. Torgue

    Journal of Nuclear Medicine September 26, 2024, jnumed.124.268101; DOI: https://doi.org/10.2967/jnumed.124.268101

  • Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery

    Lilit Schweiger, Tobias Maurer, Ricarda Simon, Thomas Horn, Matthias Heck, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher

    Journal of Nuclear Medicine September 26, 2024, jnumed.124.268151; DOI: https://doi.org/10.2967/jnumed.124.268151

  • Evaluation of Fibroblast Activation Protein Expression Using 68Ga-FAPI46 PET in Hypertension-Induced Tissue Changes

    Jung Woo Byun, Jin Chul Paeng, Young Ju Kim, Seung-Pyo Lee, Yun-Sang Lee, Hongyoon Choi, Keon Wook Kang and Gi Jeong Cheon

    Journal of Nuclear Medicine September 26, 2024, jnumed.124.267489; DOI: https://doi.org/10.2967/jnumed.124.267489

  • Open Access

    Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study

    Frédéric Pouliot, Fred Saad, Etienne Rousseau, Patrick O. Richard, Atefeh Zamanian, Stephan Probst, Éric Lévesque, Vincent Castonguay, Nicolas Marcoux, Michele Lodde, Daniel Juneau, Zineb Hamilou, Jean-Baptiste Lattouf, François-Alexandre Buteau, Michel Pavic, Jean-François Castilloux, Bertrand Neveu, Guillaume F. Bouvet, Catherine Allard, Amélie Tétu, Brigitte Guérin, Jean-Mathieu Beauregard and for the 3TMPO Investigators

    Journal of Nuclear Medicine September 26, 2024, jnumed.124.268020; DOI: https://doi.org/10.2967/jnumed.124.268020

  • Efficacy and Toxicity of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data

    Vishnu Murthy, Andrew F. Voter, Kathleen Nguyen, Martin Allen-Auerbach, Lucia Chen, Sydney Caputo, Elisa Ledet, Abraham Akerele, Abuzar Moradi Tuchayi, Courtney Lawhn-Heath, Tingchang Wang, Michael A. Carducci, Martin G. Pomper, Channing J. Paller, Johannes Czernin, Lilja B. Solnes, Thomas A. Hope, Oliver Sartor, Jeremie Calais and Andrei Gafita

    Journal of Nuclear Medicine September 26, 2024, jnumed.124.267816; DOI: https://doi.org/10.2967/jnumed.124.267816

  • MIRD Pamphlet No. 30: MIRDfit—A Tool for Fitting of Biodistribution Time–Activity Data for Internal Dosimetry

    Lukas M. Carter, Juan Camilo Ocampo Ramos, Seval Beykan Schuerrle, Harry Marquis, Michael Lassmann, Wesley E. Bolch and Adam L. Kesner

    Journal of Nuclear Medicine September 26, 2024, jnumed.124.268011; DOI: https://doi.org/10.2967/jnumed.124.268011

September 19, 2024

  • Reimagining Biologically Adapted Somatostatin Receptor–Targeted Radionuclide Therapy: Perspectives Based on Personal Experience and Observations on Recent Trials

    David Taïeb, Desirée Deandreis and Rodney J. Hicks

    Journal of Nuclear Medicine September 19, 2024, jnumed.124.268136; DOI: https://doi.org/10.2967/jnumed.124.268136

  • Is the Clinical Application of CXCR4 Imaging in the Diagnosis and Management of Primary Aldosteronism Really Happening?

    Xiang Li, Jie Ding, Stefanie Hahner, Martin Reincke, Marcus Hacker, Constantin Lapa and Li Huo

    Journal of Nuclear Medicine September 19, 2024, jnumed.124.268145; DOI: https://doi.org/10.2967/jnumed.124.268145

  • Initial Experience with [177Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction

    Andrei Gafita, Andrew Voter, Somya Shesadri, Avery Spitz, Catherine H. Marshall, Steven P. Rowe, Mark C. Markwoski, Martin G. Pomper, A. Cahid Civelek, Michael A. Carducci, Samuel R. Denmeade, Jeffrey Young, Kenneth J. Pienta, Channing J. Paller and Lilja B. Solnes

    Journal of Nuclear Medicine September 19, 2024, jnumed.124.267723; DOI: https://doi.org/10.2967/jnumed.124.267723

  • Challenges with 177Lu-PSMA-617 Radiopharmaceutical Therapy in Clinical Practice

    Hossein Jadvar, Amir Iravani, Lisa Bodei and Jeremie Calais

    Journal of Nuclear Medicine September 19, 2024, jnumed.124.268023; DOI: https://doi.org/10.2967/jnumed.124.268023

  • Open Access

    Validation of a Simplified Tissue-to-Reference Ratio Measurement Using SUVR to Assess Synaptic Density Alterations in Alzheimer Disease with [11C]UCB-J PET

    Juan J. Young, Ryan S. O’Dell, Mika Naganawa, Takuya Toyonaga, Ming-Kai Chen, Nabeel B. Nabulsi, Yiyun Huang, Emma Cooper, Alyssa Miller, Jessica Lam, Kara Bates, Audrey Ruan, Kimberly Nelsen, Elaheh Salardini, Richard E. Carson, Christopher H. van Dyck and Adam P. Mecca

    Journal of Nuclear Medicine September 19, 2024, jnumed.124.267419; DOI: https://doi.org/10.2967/jnumed.124.267419

September 5, 2024

  • First-in-Human Total-Body PET/CT Imaging Using 89Zr-Labeled MUC5AC Antibody in a Patient with Pancreatic Adenocarcinoma

    Harshad R. Kulkarni, Kevin A. Maupin, Tina Brennan, Jens Forsberg, Dan Rogers, Mark Olson, Brandon R. Mancini, Anthony Chang, Sreenivasa R. Chandana and Ryohei Kobayashi

    Journal of Nuclear Medicine September 5, 2024, jnumed.124.268074; DOI: https://doi.org/10.2967/jnumed.124.268074

  • The Translation of Dosimetry into Clinical Practice: What It Takes to Make Dosimetry a Mandatory Part of Clinical Practice

    Manuel Bardiès, Glenn Flux and Katarina Sjögreen Gleisner

    Journal of Nuclear Medicine September 5, 2024, jnumed.124.267742; DOI: https://doi.org/10.2967/jnumed.124.267742

August 14, 2024

  • The Costs to Our Patients

    Michael G. Stabin

    Journal of Nuclear Medicine August 14, 2024, jnumed.124.268290; DOI: https://doi.org/10.2967/jnumed.124.268290

July 8, 2021

  • The Annual Journal Impact Factor Saga

    Johannes Czernin

    Journal of Nuclear Medicine July 8, 2021, jnumed.121.262860; DOI: https://doi.org/10.2967/jnumed.121.262860

April 23, 2021

  • The added value of 18F-FDG PET/CT compared to 68Ga-PSMA PET/CT in patients with castration-resistant prostate cancer

    Ruohua Chen, Yining Wang, Yinjie Zhu, Yiping Shi, Lian Xu, Gang Huang and Jianjun Liu

    Journal of Nuclear Medicine April 23, 2021, jnumed.121.262250; DOI: https://doi.org/10.2967/jnumed.121.262250

November 13, 2020

  • Humana and 18F-FDG PET/CT: Another Sequel to the Injustice of Being Judged by the Errors of Others

    Johannes Czernin and Andrei Iagaru

    Journal of Nuclear Medicine November 13, 2020, jnumed.120.260208; DOI: https://doi.org/10.2967/jnumed.120.260208

June 8, 2020

  • Impact of the ISCHEMIA Trial on Stress Nuclear Myocardial Perfusion Imaging

    Venkatesh Locharla Murthy, Timothy M. Bateman, Wengen Chen, Saurabh Malhotra, Edward Miller, Terrence Ruddy and Vasken Dilsizian

    Journal of Nuclear Medicine June 8, 2020, jnumed.120.245399; DOI: https://doi.org/10.2967/jnumed.120.245399

May 15, 2020

  • Open Access

    Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMI

    Hicham Skali, Venkatesh L. Murthy, Mouaz H. Al-Mallah, Tim M. Bateman, Rob Beanlands, Nathan Better, Dennis A. Calnon, Vasken Dilsizian, Alessia Gimelli, Robert Pagnanelli, Donna M. Polk, Prem Soman, Randall C. Thompson, Andrew J. Einstein and Sharmila Dorbala

    Journal of Nuclear Medicine May 15, 2020, jnumed.120.246686; DOI: https://doi.org/10.2967/jnumed.120.246686

May 1, 2020

  • Editor's Page: Unacceptable Denials

    Johannes Czernin and Martin Allen-Auerbach

    Journal of Nuclear Medicine May 1, 2020, jnumed.120.248534; DOI: https://doi.org/10.2967/jnumed.120.248534

Pages

  • Next
  • 1
  • 2
Published Ahead of Print | Journal of Nuclear Medicine (2024)
Top Articles
Latest Posts
Recommended Articles
Article information

Author: Foster Heidenreich CPA

Last Updated:

Views: 6116

Rating: 4.6 / 5 (76 voted)

Reviews: 83% of readers found this page helpful

Author information

Name: Foster Heidenreich CPA

Birthday: 1995-01-14

Address: 55021 Usha Garden, North Larisa, DE 19209

Phone: +6812240846623

Job: Corporate Healthcare Strategist

Hobby: Singing, Listening to music, Rafting, LARPing, Gardening, Quilting, Rappelling

Introduction: My name is Foster Heidenreich CPA, I am a delightful, quaint, glorious, quaint, faithful, enchanting, fine person who loves writing and wants to share my knowledge and understanding with you.